E2F transcription factor network

No Pathway Network information available for E2F transcription factor network

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with E2F transcription factor network SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Bladder cancerEnrichmentATM, BRCA1, CDKN1A, CDKN2A, RB16.60
2Inherited cancer-predisposing syndromeEnrichmentATM, BRCA1, CDKN1B, CDKN2A, CEBPA, DHFR, RB15.47
3Multiple endocrine neoplasia, type iEnrichmentCDKN1A, CDKN1B, CDKN2C5.42
4Pancreatic cancerEnrichmentATM, BRCA1, CDKN2A, RBBP85.22
5Ovarian cancerEnrichmentATM, BRCA1, CDKN1B, CDKN2A, RB13.89
6Endometrial cancerEnrichmentATM, BRCA1, DHFR3.86
7Small cell cancer of the lungEnrichmentRB1, TP733.86
8Meier-gorlin syndrome 1EnrichmentCDC6, ORC12.99
9Gastric cancerEnrichmentATM, BRCA1, CDKN2A2.93
10Uterine corpus cancerEnrichmentATM, BRCA12.90
11Lip and oral cavity carcinomaEnrichmentCDKN2A, RB12.83
12Breast-ovarian cancer, familial 1EnrichmentATM, BRCA12.76
13Palmoplantar keratoderma, punctate type iiEnrichmentBRCA12.31
14Van esch-o'driscoll syndromeEnrichmentPOLA12.31
15Seckel syndrome 2EnrichmentRBBP82.31
16Asthma-related traits 1EnrichmentPTGDR2.31
17Neurodevelopmental disorder with absent language and variable seizuresEnrichmentWASF12.31
18Ciliary dyskinesia, primary, 47, and lissencephalyEnrichmentTP732.31
19Pigmentary disorder, reticulate, with systemic manifestations, x-linkedEnrichmentPOLA12.31
20Renal cell carcinoma, xp11-associatedEnrichmentTFE32.31
21Intellectual developmental disorder, x-linked, syndromic, with pigmentary mosaicism and coarse faciesEnrichmentTFE32.31
22Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6EnrichmentRRM12.31
23Infant-type hemispheric gliomaEnrichmentBRCA12.31
24Plasminogen activator inhibitor-1 deficiencyEnrichmentSERPINE12.31
25Jawad syndromeEnrichmentRBBP82.31
26Neuroendocrine tumorEnrichmentCDKN1B2.31
27Endometrial serous adenocarcinomaEnrichmentATM2.31
28Megaloblastic anemia due to dihydrofolate reductase deficiencyEnrichmentDHFR2.31
29Meier-gorlin syndrome 5EnrichmentCDC62.31
30Deafness, autosomal dominant 75EnrichmentTRRAP2.31
31Blepharophimosis-impaired intellectual development syndromeEnrichmentSMARCA22.31
32Developmental delay with or without dysmorphic facies and autismEnrichmentTRRAP2.31
33Spinocerebellar ataxia, autosomal recessive 26EnrichmentXRCC12.31
34Trilateral retinoblastomaEnrichmentRB12.31
35Cdkn2a cancer predispositionEnrichmentCDKN2A2.31
36B-cell non-hodgkin lymphomaEnrichmentATM2.31
37Wilms tumor 7EnrichmentTRIM282.31
38Acute myeloid leukemia with mutated cebpaEnrichmentCEBPA2.31
39Congenital plasminogen activator inhibitor type 1 deficiencyEnrichmentSERPINE12.31
40Primary peritoneal carcinomaEnrichmentBRCA12.31
41Lung oat cell carcinomaEnrichmentRB12.31
42Precursor t-cell acute lymphoblastic leukemiaEnrichmentCDKN2A, MYC2.26
43Prostate cancerEnrichmentATM, BRCA12.06
44Melanoma-astrocytoma syndromeEnrichmentCDKN2A2.01
45Burkitt lymphomaEnrichmentMYC2.01
46Quebec platelet disorderEnrichmentPLAU2.01
47Alveolar soft part sarcomaEnrichmentTFE32.01
48Melanoma, cutaneous malignant 2EnrichmentCDKN2A2.01
49Chromosome 13q14 deletion syndromeEnrichmentRB12.01
50Multiple endocrine neoplasia, type ivEnrichmentCDKN1B2.01
51Gabriele-de vries syndromeEnrichmentYY12.01
52Fanconi anemia, complementation group sEnrichmentBRCA12.01
53Cardiac valvular dysplasia, x-linkedEnrichmentATM2.01
54Pancreatic cancer 4EnrichmentBRCA12.01
55Melanoma-pancreatic cancer syndromeEnrichmentCDKN2A2.01
56High grade gliomaEnrichmentATM2.01
57Developmental and epileptic encephalopathy 78EnrichmentYY12.01
58InsulinomaEnrichmentYY12.01
59T-cell prolymphocytic leukemiaEnrichmentATM2.01
60Inflammatory breast carcinomaEnrichmentBRCA12.01
61Blepharophimosis - intellectual disability syndromeEnrichmentSMARCA22.01
62Dyskeratosis congenita, digenicEnrichmentTYMS2.01
63Peritoneum cancerEnrichmentBRCA12.01
64Bilateral breast cancerEnrichmentBRCA12.01
65Familial retinoblastomaEnrichmentRB12.01
66RetinoblastomaEnrichmentRB11.84
67Ataxia-telangiectasiaEnrichmentATM1.84
68Polycythemia veraEnrichmentATM1.84
69Partington syndromeEnrichmentPOLA11.84
70Osteogenic sarcomaEnrichmentRB11.84
71Woolly hair, autosomal recessive 3EnrichmentRB11.84
72Miller-dieker lissencephaly syndromeEnrichmentHIC11.84
73Familial adenomatous polyposis 4EnrichmentDHFR1.84
74Hypotrichosis 8EnrichmentRB11.84
75Koolen-de vries syndromeEnrichmentATM1.84
76High-grade b-cell lymphoma double-hit/triple-hitEnrichmentMYC1.84
77Squamous cell carcinomaEnrichmentRB11.84
78AdenocarcinomaEnrichmentATM1.84
79Bone osteosarcomaEnrichmentRB11.84
80Respiratory failureEnrichmentTP731.84
81Renal cell carcinomaEnrichmentTFE31.84
82Polyposis syndrome, hereditary mixed, 1EnrichmentBRCA11.71
83Nicolaides-baraitser syndromeEnrichmentSMARCA21.71
84CholangiocarcinomaEnrichmentBRCA11.71
85Lynch syndrome 4EnrichmentRB11.71
86Mantle cell lymphomaEnrichmentATM1.71
87BlepharophimosisEnrichmentSMARCA21.71
88Malignant epithelioid hemangioendotheliomaEnrichmentTFE31.71
89Smarca2-related nicolaides-baraitser syndromeEnrichmentSMARCA21.71
90Primary hyperparathyroidismEnrichmentCDKN1B1.71
91Oculomotor apraxiaEnrichmentATM1.71
92Pseudomyogenic hemangioendotheliomaEnrichmentSERPINE11.71
93Hereditary breast carcinomaEnrichmentATM, BRCA11.71
94Alzheimer disease 2EnrichmentPLAU1.62
95Breast-ovarian cancer, familial 2EnrichmentBRCA11.62
96Ciliary dyskinesia, primary, 40EnrichmentE2F61.62
97GlioblastomaEnrichmentATM1.62
98Inherited acute myeloid leukemiaEnrichmentCEBPA1.62
99Acute myeloid leukemia with t(8;21)(q22;q22) translocationEnrichmentCEBPA1.62
100Li-fraumeni syndromeEnrichmentCDKN2A1.54
101Wilms tumor 5EnrichmentTRIM281.54
102Adrenocortical carcinomaEnrichmentCDKN2A1.54
103Clear cell renal cell carcinomaEnrichmentATM1.54
104Lung squamous cell carcinomaEnrichmentCDKN2A1.54
105Hereditary breast ovarian cancer syndromeEnrichmentATM, BRCA11.53
106Myeloma, multipleEnrichmentATM, CDKN2C1.52
107Renal cell carcinoma, papillary, 1EnrichmentATM1.47
108Renal cell carcinoma with mit translocationsEnrichmentTFE31.47
109B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentCDKN2A1.47
110Colonic benign neoplasmEnrichmentATM1.37
111Lynch syndrome 1EnrichmentATM1.32
112Leukemia, chronic lymphocyticEnrichmentATM1.32
113MelanomaEnrichmentCDKN2A1.32
114Breast cancerEnrichmentATM, BRCA11.29
115Immune deficiency diseaseEnrichmentATM1.28
116Leukemia, acute lymphoblasticEnrichmentCDKN2A1.28
117Familial colorectal cancer type xEnrichmentATM1.28
118Lung cancer susceptibility 3EnrichmentRB11.18
119Periventricular nodular heterotopiaEnrichmentBRCA11.18
120Seckel syndromeEnrichmentRBBP81.18
121Pituitary stalk interruption syndromeEnrichmentSMARCA21.18
122Colorectal cancerEnrichmentATM, BRCA11.17
123Renal cell carcinoma, nonpapillaryEnrichmentATM1.15
124Wilms tumor 1EnrichmentTRIM281.15
125RhabdomyosarcomaEnrichmentBRCA11.12
126GliosarcomaEnrichmentATM1.12
127Alzheimer disease, familial, 1EnrichmentPLAU1.10
128Melanoma, cutaneous malignant 1EnrichmentCDKN2A1.10
129Polycystic liver diseaseEnrichmentCDC25A1.10
130Giant cell glioblastomaEnrichmentATM1.10
131Autosomal dominant polycystic liver diseaseEnrichmentCDC25A1.10
132Dyskeratosis congenitaEnrichmentTYMS1.05
133Lung cancerEnrichmentBRCA10.84
134Fanconi anemia, complementation group aEnrichmentBRCA10.80
135Leukemia, acute myeloidEnrichmentCEBPA0.75
136Rare autosomal dominant non-syndromic sensorineural deafness type dfnaEnrichmentTRRAP0.65
137Complex neurodevelopmental disorderEnrichmentWASF10.34

Loading...
Loading...
Loading...